文献速递临床试验与 GCP

膝动脉栓塞术治疗轻中度膝骨关节炎:随机假手术对照临床试验的方案设计

Genicular artery embolization as a novel treatment for mild to moderate knee osteoarthritis: protocol design of a randomized sham-controlled clinical trial.
PubMed 文献 · Trials · 2022-01-08

这是一项随机假手术对照试验,计划招募58例轻中度膝骨关节炎患者,按1:1随机分入膝动脉栓塞术组或假手术组,主要结局为4个月时KOOS疼痛子量表较基线的变化,旨在评估膝动脉栓塞术的疗效。

要点

  • 58例轻中度膝骨关节炎患者按1:1随机接受膝动脉栓塞术或假手术治疗。
  • 主要结局为4个月时KOOS疼痛子量表评分较基线的变化。
  • 次要结局包括骨关节炎相关问卷、压痛阈值及MRI特征(尤其滑膜炎和骨髓病变)。

核心结论

  • 该试验将确定膝动脉栓塞术相较于假手术治疗的疗效。
  • 在开展更大规模的效力研究及最终将该治疗纳入日常临床实践之前,评估这一点很重要。

研究设计与样本

  • 随机假手术对照临床试验,计划招募58例轻中度膝骨关节炎患者,按1:1比例随机分配至治疗组或对照组。
  • 治疗组参与者接受膝动脉栓塞术,对照组参与者接受假手术治疗。
  • 结局在基线及1、4、8、12个月时通过问卷、压痛阈值测试和MR成像进行评估。

主要发现

  • 主要结局为4个月时膝关节损伤和骨关节炎结局评分(KOOS)疼痛子量表较基线的变化。
  • 次要结局包括骨关节炎相关问卷的变化、压痛阈值以及骨关节炎相关MRI特征,特别是滑膜炎和骨髓病变。

关键数值与推荐

  • 主要结局为4个月时KOOS疼痛子量表较基线的变化。
  • 次要结局包括骨关节炎相关问卷变化、压痛阈值和骨关节炎相关MRI特征(尤其滑膜炎和骨髓病变)。
  • MR成像方案设计用于(半)定量评估膝关节骨关节炎。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Knee osteoarthritis is a common disease with pain as the most prevalent symptom. Previous cohort studies have shown genicular artery embolization to reduce pain symptoms in patients with mild to moderate knee osteoarthritis. Patients resistant to conservative therapy but not eligible yet for surgical treatment due to young age or comorbidities may profit from an effective and sustained pain reduction treatment. This study is a randomized sham-controlled trial to evaluate the efficacy of genicular artery embolization in patients with knee osteoarthritis. METHODS AND ANALYSIS: Fifty-eight patients with mild-to-moderate knee osteoarthritis will be recruited and randomly allocated to the treatment or control group in a 1:1 ratio. Participants in the treatment group will undergo genicular artery embolization. Patients in the control group will undergo sham treatment. Outcome measurements will be assessed at baseline and after 1, 4, 8, and 12 months with questionnaires, pressure pain threshold testing, and MR imaging. The MR imaging protocol is designed to (semi)quantitatively assess osteoarthritis in the knee joint. The primary outcome is the change from baseline of the Knee injury and Osteoarthritis Outcome Score (KOOS) pain subscale after 4 months. Secondary outcomes include change in osteoarthritis-related questionnaires, pressure pain threshold, and OA-related MRI features, particularly synovitis and bone marrow lesions. ETHICS AND DISSEMINATION: This trial will determine the efficacy of genicular artery embolization compared to a sham treatment. This is of importance to assess before proceeding to larger-scale efficiency studies and, ultimately, implementing this treatment into day to day clinical practice. TRIAL REGISTRATION: ClinicalTrials.gov NCT03884049. Registered on 21 March 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. van Zadelhoff TA, Moelker A, Bierma-Zeinstra SMA, et al. Genicular artery embolization as a novel treatment for mild to moderate knee osteoarthritis: protocol design of a randomized sham-controlled clinical trial. Trials. 2022. PMID: 34998425. doi:10.1186/s13063-021-05942-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。